0 Commentaires
0 Parts
394 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Danaher (DHR) raised its 2026 profit outlook as core sales grew only 3.0%Adjusted earnings per share rose 11.5% in the third quarter while core sales grew 3.0%, and the full-year range moved up by less than the quarter's gain. Cash flow and segment mix tell a narrower story. Danaher Corporation (DHR) reported third-quarter 2026 results on October 21 and raised its full-year adjusted earnings guidance. Adjusted diluted earnings per share reached $2.11, up from $1.89...0 Commentaires 0 Parts 10 Vue 0 Aperçu
-
Endonucleases Market Future Trends and Revenue OpportunitiesThe endonucleases market is experiencing robust growth as advancements in molecular biology, genetic engineering, and biotechnology continue to transform healthcare and life sciences research. Endonucleases are enzymes that cleave nucleic acid strands at specific internal sites, making them essential tools for DNA manipulation, gene editing, cloning, sequencing, and genome analysis. Their...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
US Cell Lysis Market Growth Drivers, Challenges and OpportunitiesThe United States is a major market for cell lysis technologies, supported by extensive investments in biotechnology, pharmaceutical research, and molecular diagnostics. The presence of leading life science companies, advanced research institutions, and a strong focus on genomics and proteomics research continues to drive demand for efficient cell lysis solutions. Additionally, growing adoption...0 Commentaires 0 Parts 1KB Vue 0 Aperçu